Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Franceschi

Showing results (91-100 of 162) with videos related to

Pageof 17
Sort By:
Neuro-Oncology|October 1, 2024
Targeted radionuclide therapy for patients with central nervous system metastasis: Overlooked potential?Emilie Le Rhun, Nathalie L Albert, Martin Hüllner, et al.
Future Oncology (London, England)|July 25, 2019
Concordance between RTOG and EORTC prognostic criteria in low-grade gliomasEnrico Franceschi, Antonella Mura, Giuseppe Lamberti, et al.
Pathology, Research and Practice|April 22, 2021
The clinical and prognostic role of ALK in glioblastomaEnrico Franceschi, Dario De Biase, Vincenzo Di Nunno, et al.
Clinical Drug Investigation|August 17, 2021
Is Molecular Tailored-Therapy Changing the Paradigm for CNS Metastases in Breast Cancer?Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
Pathology, Research and Practice|April 22, 2021
IDH1<sup>105GGT</sup> single nucleotide polymorphism improves progression free survival in patients with IDH mutated grade II and III gliomasEnrico Franceschi, Dario De Biase, Vincenzo Di Nunno, et al.
Tumori|May 18, 2021
Expertise is crucial to prolong survival in average risk medulloblastoma: long-term results of a retrospective studyEnrico Franceschi, Santino Minichillo, Alicia Tosoni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 30, 2026
Cutting-edge approaches in pet imaging for gliomas: current applications for neurooncologists and the path to theranostic breakthroughsLidia Gatto, Riccardo Mei, Martina Stasolla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2006
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO studyAlba A Brandes, Alicia Tosoni, Giovanna Cavallo, et al.
Diagnostics (Basel, Switzerland)|September 28, 2021
Correction: Visani et al. miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children. <i>Diagnostics</i> 2020, <i>10</i>, 265Michela Visani, Gianluca Marucci, Dario de Biase, et al.
Diagnostics (Basel, Switzerland)|May 6, 2020
miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and ChildrenMichela Visani, Gianluca Marucci, Dario de Biase, et al.
Pageof 17

Showing results (91-100 of 162) with videos related to

Sort By:
Pageof 17
Neuro-Oncology|October 1, 2024
Targeted radionuclide therapy for patients with central nervous system metastasis: Overlooked potential?Emilie Le Rhun, Nathalie L Albert, Martin Hüllner, et al.
Future Oncology (London, England)|July 25, 2019
Concordance between RTOG and EORTC prognostic criteria in low-grade gliomasEnrico Franceschi, Antonella Mura, Giuseppe Lamberti, et al.
Pathology, Research and Practice|April 22, 2021
The clinical and prognostic role of ALK in glioblastomaEnrico Franceschi, Dario De Biase, Vincenzo Di Nunno, et al.
Clinical Drug Investigation|August 17, 2021
Is Molecular Tailored-Therapy Changing the Paradigm for CNS Metastases in Breast Cancer?Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, et al.
Pathology, Research and Practice|April 22, 2021
IDH1<sup>105GGT</sup> single nucleotide polymorphism improves progression free survival in patients with IDH mutated grade II and III gliomasEnrico Franceschi, Dario De Biase, Vincenzo Di Nunno, et al.
Tumori|May 18, 2021
Expertise is crucial to prolong survival in average risk medulloblastoma: long-term results of a retrospective studyEnrico Franceschi, Santino Minichillo, Alicia Tosoni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 30, 2026
Cutting-edge approaches in pet imaging for gliomas: current applications for neurooncologists and the path to theranostic breakthroughsLidia Gatto, Riccardo Mei, Martina Stasolla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2006
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO studyAlba A Brandes, Alicia Tosoni, Giovanna Cavallo, et al.
Diagnostics (Basel, Switzerland)|September 28, 2021
Correction: Visani et al. miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children. <i>Diagnostics</i> 2020, <i>10</i>, 265Michela Visani, Gianluca Marucci, Dario de Biase, et al.
Diagnostics (Basel, Switzerland)|May 6, 2020
miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and ChildrenMichela Visani, Gianluca Marucci, Dario de Biase, et al.
Pageof 17